NeuroSense Therapeutics Ltd. (NRSN) Financials
NRSN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 5.4 million | 5.6 million |
| 2023-06-30 | 7.9 million | 9.4 million |
| 2023-03-31 | 5.3 million | 2.4 million |
| 2022-12-31 | 7.7 million | 2.1 million |
NRSN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | ? | ? |
| 2023-06-30 | 1784 | 1784 |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 5105 | 5105 |
NRSN Net Income
No data available :(
NRSN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 4.8 million | - | 84000 |
| 2023-06-30 | 7.1 million | - | 104000 |
| 2023-03-31 | 4.4 million | - | 126000 |
| 2022-12-31 | 7.1 million | - | 211000 |
NRSN Shares Outstanding
NRSN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 1.6 million | 1.3 million | - |
| 2023-06-30 | - | 1.9 million | 1.6 million | - |
| 2023-03-31 | - | 2.1 million | 1.5 million | - |
| 2022-12-31 | - | 1.5 million | 1.8 million | - |
NRSN Cost of Revenue
No data available :(
NRSN
Price: $1.27
52 week price:
Earnings Per Share: -0.83 USD
P/E Ratio: -1.35
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 108700
Market Capitalization: 25.0 million